Document Type



Media is loading

Publication Date



Liver transplantation (LT) is the only definitive, life-saving treatment for patients with end-stage liver disease (ESLD), yet the disparity between wait-listed and transplanted patients continues to widen. To help improve the sustainable allocation of this scarce resource, focus has been on the delivery of behavioral and addiction therapies to patients, both pre- and post- LT, to increase sobriety (especially in alcohol-related ESLD) and adherence. However, few attempts have been made to summarize the current literature rendering providers without guidance for ideal timing, treatment components, and duration of aforementioned therapies. Optimization of LT outcomes and patient survival depends on interventions focused on addressing alcohol recidivism and medical adherence. Recognizing factors contributory to nonadherence and alcohol recidivism in ESLD and LT patients is fundamental. Thereafter, implementation of therapies inclusive of individual and/or group approaches to deliver motivational, cognitive-behavioral and self-improvement interventions either in-person or remotely in an integrated, multidisciplinary fashion is imperative to impart comprehensive care to transplant patients.

First Advisor

Sujit Sakpal

Second Advisor

Hector Saucedo Crespo

Research Area

Interdisciplinary, Health